PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 263-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia

By  

Cytogenetic and Genome Research, Vol. 150, Iss. 3-4, 2017-02 ,pp. : 242-252

Karger

Access to resources Recommend Favorite

A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 550-562

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody‐based therapies in B‐cell lineage acute lymphoblastic leukaemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 99-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 813-817

John Wiley & Sons Inc

Access to resources Recommend Favorite